VNRX
VolitionRx LimitedRecent alerts on VNRX
All signals →
SEC filing
VNRX Obtains $9.9M Convertible Note Waiver from Lind, Avoids Default, Preserves Conversion Option at 90% of VWAP
10d ago
SEC filing
VNRX Reduces Board to 7 Directors After Mickie Henshall Declines Re‑Election
17d ago
News
VolitionRx anticipates first DETECSEPS patient in September as Q1 revenue rises to about $1M
17d ago
News
VolitionRX GAAP EPS of -$0.97 misses by $0.26, revenue of $0.99M beats by $0.46M
18d ago
SEC filing
VNRX Announces 1-for-20 Reverse Stock Split Approved by Shareholders, Effective April 28, 2026
34d ago
News
Fortress’ Latest Private Debt Fund Seeks to Lure Insurance Firms
106d ago
News
Volition Continues to Extend Access to Nu.Q® Vet Cancer Test
133d ago
News
Volition Sponsors Symposium at Veterinary Meeting and Expo
137d ago
News
VolitionRx secures $2M financing through amended securities agreement; shares up
145d ago
News
VolitionRx Announces Breakthrough Clinical Data for Nu.Q® Vet Cancer Test in Cats
145d ago
Scanner
Unusual volume (z=12.1)
166d ago
Get push alerts for VNRX
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS